ARTICLE | Clinical News
Boehringer unveils diabetes pipeline
October 18, 2008 1:36 AM UTC
Boehringer Ingelheim (Ingelheim, Germany) announced its entrance into the Type II diabetes drug development space as it unveiled three products in late-stage testing. The compounds include: Ondero ( B...